000 01091 a2200325 4500
005 20250517052040.0
264 0 _c20160718
008 201607s 0 0 ger d
022 _a1433-0563
024 7 _a10.1007/s00120-015-3940-y
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSchaefer, R M
245 0 0 _a[The dilemma with PREFERE (and other studies)].
_h[electronic resource]
260 _bDer Urologe. Ausg. A
_cOct 2015
300 _a1437-8 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aChemoradiotherapy
_xadverse effects
650 0 4 _aEvidence-Based Medicine
650 0 4 _aGermany
650 0 4 _aHarm Reduction
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMedical Errors
_xprevention & control
650 0 4 _aProstatectomy
_xadverse effects
650 0 4 _aProstatic Neoplasms
_xdiagnosis
650 0 4 _aRisk Assessment
_xmethods
650 0 4 _aTreatment Outcome
773 0 _tDer Urologe. Ausg. A
_gvol. 54
_gno. 10
_gp. 1437-8
856 4 0 _uhttps://doi.org/10.1007/s00120-015-3940-y
_zAvailable from publisher's website
999 _c25242211
_d25242211